BackgroundCirculating tumor DNA (ctDNA) is an emerging biomarker in malignant melanoma(MM). and high levels of ctDNA may reflect a higher tumor load. However. its prognostic value for MM receiving immune checkpoint inhibitors(ICI) remains controversial. https://yeswellneses.shop/product-category/iodine/